Takeda Pharmaceutical
(OTC) TKPHF
Takeda Pharmaceutical Financials at a Glance
Market Cap
$54.54B
Revenue (TTM)
$4.47T
Net Income (TTM)
$113.02B
EPS (TTM)
$0.48
P/E Ratio
69.66
Dividend
$1.33
Beta (Volatility)
0.07 (Low)
Dividend
$1.33
Beta (Volatility)
0.07 (Low)
Price
$34.52
Volume
186
Open
$34.52
Price
$34.52
Volume
186
Open
$34.52
Previous Close
$34.52
Daily Range
$34.52 - $34.52
52-Week Range
$26.10 - $39.20
Dividend
$1.33
Beta (Volatility)
0.07 (Low)
Price
$34.52
Volume
186
Open
$34.52
Previous Close
$34.52
Daily Range
$34.52 - $34.52
52-Week Range
$26.10 - $39.20
TKPHF News
TKPHF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Takeda Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
47,455
CEO
Christophe Weber, PhD
Website
www.takeda.comHeadquarters
Tokyo, 103-8668, JP
TKPHF Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
10%
Net Income Margin
3%
Return on Equity
2%
Return on Capital
4%
Return on Assets
1%
Earnings Yield
1.44%
Dividend Yield
0.04%
Payout Ratio
2.77%
Stock Overview
Market Cap
$54.54B
Shares Outstanding
1.58B
Volume
186
Short Interest
0.00%
Avg. Volume
93.04K
Financials (TTM)
Gross Profit
$3.00T
Operating Income
$342.59B
EBITDA
$1.07T
Operating Cash Flow
$1.06T
Capital Expenditure
$379.63B
Free Cash Flow
$677.56B
Cash & ST Invst.
$405.59B
Total Debt
$4.52T
Takeda Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.19T
+4.2%
Gross Profit
$649.20B
-10.7%
Gross Margin
54.43%
N/A
Market Cap
$54.54B
N/A
Market Cap/Employee
$1.11M
N/A
Employees
49,281
N/A
Net Income
$103.73B
+336.0%
EBITDA
$448.52B
+83.1%
Quarterly Fundamentals
Net Cash
$4.20T
+2.6%
Accounts Receivable
$758.58B
+3.2%
Inventory
$1.41T
+13.0%
Long Term Debt
$4.27T
-9.2%
Short Term Debt
$583.66B
+330.8%
Return on Assets
0.73%
N/A
Return on Invested Capital
3.59%
N/A
Free Cash Flow
$307.31B
-6.1%
Operating Cash Flow
$348.98B
-9.1%